OECD GLP compliance means that the planning, conduct, monitoring, reporting, and archiving of non-clinical studies are carried out in accordance with internationally accepted quality standards.

Yes. Our laboratory operates in full compliance with the OECD Good Laboratory Practice (GLP) principles, ensuring that all non-clinical studies are conducted in accordance with strict standards for quality, documentation, and data integrity. Our GLP-compliant system is supported by a robust Quality Assurance framework and regular inspections by regulatory authorities, ensuring that all data generated is reliable, traceable, and suitable for submission to international regulatory bodies.

Yes. Our laboratory is regularly inspected by the relevant regulatory authorities to ensure ongoing compliance with Good Laboratory Practice (GLP) standards and applicable international guidelines. These inspections verify the integrity of our quality systems, study conduct, documentation practices, and data management processes, ensuring that all results meet the expectations of global regulatory agencies.

Yes. Our studies are internationally recognized when conducted in accordance with OECD Good Laboratory Practice (GLP) principles under the OECD Mutual Acceptance of Data (MAD) system. This ensures that our study reports and the data obtained are recognized by regulatory authorities in OECD member countries, supporting global product registrations and regulatory submissions without the need for retesting in different regions. Additionally, reports issued by our laboratories accredited to the ISO/IEC 17025 standard may be recognized internationally if the accreditation body is a signatory to the ILAC MRA (International Laboratory Accreditation Cooperation – Mutual Recognition Arrangement).

The ILAC MRA is an international agreement aimed at ensuring the mutual recognition of test and calibration results issued by accredited laboratories across different countries. This system helps reduce the need for retesting while enhancing technical reliability.

We offer a wide range of preclinical research capabilities to support early-stage development and regulatory safety assessments. These include in vitro toxicology studies, biocompatibility testing, microbiological and efficacy assessments, as well as other preclinical safety evaluations conducted in accordance with OECD GLP principles when required. Our services are designed to generate reliable scientific data that supports regulatory submissions and guides clinical development pathways.

Yes. Studies conducted in accordance with OECD GLP (Good Laboratory Practice) principles may be evaluated by international regulatory authorities, including the FDA, under the OECD Mutual Acceptance of Data (MAD) system. Final acceptance depends on the scope of the study, data integrity, and compliance with relevant regulatory requirements.

Yes. We provide services through our group of laboratories, which hold comprehensive ISO/IEC 17025 accreditation.